PRECISION TRAUMA
Simple solutions for complex trauma.
We are a team dedicated to bringing innovative life-saving products to the point of injury. In order to save more lives and produce better outcomes, we identify gaps in pre-hospital trauma care and creatively fill those gaps with simplified critical capabilities. We do this by teaming with a major university research lab, executing internal development as well as external product acquisition. By taking a multi pronged approach we are able to bring the next lifesaving technology to the end user, we relentlessly pursue innovative solutions for key gaps in current medical care.
Precision Trauma Products
Our goal is to provide a full suite of bleeding control
products that cover the range of trauma scenarios.
TURN-I-KIT Bystander/First Responder: Intuitive extremity hemorrhage control
JUNCTIONAL TOURNIQUET Prehospital: Stable Junctional Hemorrhage Control
GROA Prehospital/Initial Resuscitation: Zone 2 Aortic Occlusion
INTRAPERITONEAL HEMOSTASIS DEVICE Prehospital/Initial Resuscitation:
Abdominal hemorrhage control while maintaining lower extremity perfusion
Turn-I-Kit
This is an advanced tool in the battle to save lives at the point of trauma. The Turn-I-Kit brings high efficacy field treatment to un-trained first responders. The Turn-I-Kit is simple to use and more effective than traditional tourniquets, this is a solution that can be adopted by anyone.
Designed for use by untrained first responders
Simple 3 step process to stop bleeding fast
Large surface area and even pressure provides rapid occlusion with less chance of soft tissue damage
Puts the power to stop critical bleeding in everyone’s hands
PATENT PENDING
Junctional Tourniquet-
In Development
Coming soon from Precision Trauma is the PT Junctional Tourniquet designed with the same ease of use, ergonomics and high quality as our Turn-I-Kit. The PT Junctional Tourniquet is used to control bleeding not affected by traditional tourniquets applied to the extremities. Junctional tourniquets can be applied to the groin or abdomens and have proven very helpful in providing critical time to get patients from the point of injury to emergent care. Precision Trauma is bringing this battle-tested technique to first responders in an easy to use format.
PATENT PENDING
GROA - In Development
Coming soon from Precision Trauma’s continuing relationship with MCIRCC is the GROA (Gastroesophageal Resuscitative Occlusion of the Aorta) to target Non-Compressible Torso Hemorrhage. This simplified device provides high Zone 2 occlusion of the aorta without complicated arterial access. GROA can be administered in the prehospital setting without any special equipment to dramatically increase survivability of noncompressible hemorrhage. For more information see the Journal of Trauma links demonstrating feasibility and survivability.
PATENT PENDING
Conclusion: “The GROA device was capable of achieving high zone II full aortic occlusion and may be able to serve as an effective method of aortic impingement.”
Intraperitoneal Hemostasis Device –
Future Development
Developed for prehospital/initial resuscitation of noncompressible abdominal hemorrhage. This device will allow for abdominal hemorrhage control while maintaining lower extremity perfusion. Once deployed, the device also provides an option for aortic occlusion. With simple trocar insertion and balloon inflation, initial studies show 100% survivability in a universally lethal hemorrhage model.
PATENT PENDING
Conclusion: “Our data show that the IPHD concept is capable of prolonging survival by temporarily stanching lethal NCTH of the abdomen.”
Precision Trauma exists to bring the latest technology in trauma care to the point of need in order to save lives. To learn more about how Precision Trauma is re-defining emergent medicine:
OUR PARTNERS
THE TEAM
Ethan A. Miles
M.D., FAWM, DiMMChief Executive Officer
Dr. MIles has spent his career developing best practices for emergent care at the point of injury in combat environments. His passion for saving lives by providing first responders with the best possible training and tools has led him from medical school to Regimental Surgeon in the 75th Ranger Regiment. During his time with the Rangers he has developed Award winning innovation in Whole Blood Delivery programs and oversaw the rewrite of the DoDs Combat Lifesaver Program. By founding Precision Trauma, Dr. Miles has created a pipeline to bring this learning and commitment to excellence to the civilian market.
Peter Shull
Chief Operating Officer
Mr. Shull leads the Precision Trauma operations team helping to bring new products to market while creating a platform for sustainable growth. This requires the vision and strategy developed of a long and successful military career. After serving as an Operations and Executing officer at Fort Riley’s 1st Infantry Division, Mr. Shull completed multiple overseas deployments. He eventually joined the 75th Ranger regiment as Deputy Commander and was responsible for training officers. He brings the same operational excellence to his role as COO at Precision Trauma enabling the team to continue to lead the way.
Jeffrey S. Cain
M.D., FACEPChief Medical Officer
Dr. Cain has trained thousands of personnel in emergency pre-hospital trauma care techniques and has participated in numerous disaster and mass-casualty planning scenarios for hospital facilities and communities within the United States as well as deployable hospital systems worldwide. He brings current trauma best practices and procedures from his time with the Rangers to the development team at Precision Trauma. As the Chief, Academic Division for the Department of Combat Medic Training in Fort Sam Houston, Texas, he revised the training pathway for all Army medics and facilitated transformation of the Army’s Combat Lifesaver programs and associated medical equipment. Dr. Cain is qualified to lead the application of PT products in real world environments.
ADVISORY BOARD
Kevin R. Ward
M.D., FACEP, FAAEM
Chair-Medical Advisory Board
Dr. Ward’s passion is in creating programs which encourage true integration across the disciplines of medicine, engineering, data sciences, and entrepreneurship that accelerate discovery to true patient impact. In 2015 he founded the Michigan Center for Integrative Research in Critical Care (MCIRCC) which is leveraging the multidisciplinary expertise of the University of Michigan to transform critical care through innovation, integration, and entrepreneurship. As the Director at MCIRCC, Dr. Ward is the link between on-going research and Precision Trauma’s product development process. His collaboration with the military and civilian organizations continues to bring innovation to critical care to patients around the world.